Small-caps poised to outperform thanks to biotechs, regional banks and reshoring

Mike Rode, senior investment director at American Century Investments, sits down with InvestmentNews anchor Gregg Greenberg to explain why small-caps are set to outperform due to the rise of reshoring, new IPOs and biotechs.
  • May 29, 2024
More: IN THE NASDAQ
Here's what to expect from REITs in the second half of 2025

Here's what to expect from REITs in the second half of 2025

International stock outperformance not finished yet

International stock outperformance not finished yet

Why the 'great global realignment' will boost foreign small-cap stocks

Why the 'great global realignment' will boost foreign small-cap stocks